MENU

Cancer Conversations Blog

May 3, 2016

Fox Chase Marks Silver Anniversary of its Risk Assessment Program

By: Andrea Forman, MS, LCGC; Fox Chase Conversations

Celebrating 25 years of Risk Assessment and the Families Who Make It Possible

Krisna Duong-Ly, PhD
May 2, 2016

Trainee Spotlight: Krisna Duong-Ly, PhD

By: Fox Chase Postdoctoral Program

"My work centers on identifying and characterizing novel kinase inhibitors of disease-associated mutant kinases and understanding the downstream signaling of kinases commonly activated in human cancers. My future career goals are to learn more about kinase-regulated processes and to develop novel therapeutics against kinase-driven diseases."

April 27, 2016

Melanoma Patients, Donna and Carla, Visit Capitol Hill to Lobby for Research Funding

By: Fox Chase Conversations

Melanoma patients have a special bond. The weekend of March 12 and 13 we, Donna and Carla, were offered the opportunity to travel to Washington, D.C. with the Melanoma Research Foundation.

April 22, 2016

Fox Chase Taco Night at Hope Lodge

By: Fox Chase Conversations

Nurses from a range of departments at Fox Chase Cancer Center recently came together to put on a taco night for guests staying at the nearby AstraZeneca Hope Lodge of the American Cancer Society. Hope Lodge offers lodging at no cost for out-of-area cancer patients being treated in the Philadelphia area.

April 22, 2016

Nurses Rewarded for Reducing UTIs in Patients

By: Fox Chase Conversations

Nursing units at Fox Chase Cancer Center were recently rewarded with a sweet treat after their work led to a significant decrease in catheter-associated urinary tract infections in patients.

April 22, 2016

Kickball Team Supports Hope Lodge

By: Fox Chase Conversations

The Office of Clinical Research at Fox Chase Cancer Center is kicking one out of the park in support of the AstraZeneca Hope Lodge of the American Cancer Society.

April 19, 2016

Clinical Trial of the Month

By: Fox Chase Today

This month, we are highlighting a Phase 2 Clinical Trial for patients diagnosed with muscle invasive bladder cancer that will be led by Daniel M. Geynisman, MD, a medical oncologist at Fox Chase who specializes in genitourinary cancers.

April 19, 2016

Paving the Way for Personalized Therapy

By: Fox Chase Conversations

Fox Chase Cancer Center researchers have identified a way forward for personalized cancer treatments for a wide range of cancers. Their findings can provide new insight into the mechanisms of a small molecule and investigational new drug for cancer called ONC201. The drug not only stimulates a powerful anticancer protein called TRAIL, but also the death receptor for TRAIL (also known as DR5) on tumor cells. This allows TRAIL to specifically kill tumor cells.

Pages